Large, peer-reviewed research study proves ivermectin works

The results are in from the world's largest study of ivermectin for COVID-19.

Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.

Of the 223,128 citizens of Itajaí considered for the study, a total of 159,561 subjects elected to participate: over 70% opted to take ivermectin, and 23% chose not to.

The study found a 44% reduction in COVID-19 infection rate in favor of the group that took ivermectin.

In cases where a participating citizen of Itajaí became ill with COVID-19, they were recommended not to use ivermectin or any other medication in early outpatient treatment.

The regular use of preventative ivermectin led to a 68% reduction in COVID-19 mortality, and a 56% reduction in hospitalization rate.

All subjects with symptoms were recommended not to use ivermectin, nitazoxanide, hydroxychloroquine, spironolactone, or any other drug claimed to be effective against COVID-19.
 

https://flccc.substack.com/p/large-peer-reviewed-research-study